- Long-term efficacy update of crizotinib in patients with advanced, in…
Number of the records: 1  

Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE

  1. TitleLong-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE / P. Schöffski, Kubickova M. ... [et al.]
    Another responsib. Schöffski, P. (Bibliographic antecedent)
    Kubičková, Michaela (Bibliographic antecedent)
    Redakcia Onkológia (Adapter)
    NoteEuropean Journal of Cancer, vol. 156 (2021), s. 12-23
    In Onkológia. -- ISSN 1336-8176. -- Roč. 17, č. 1 (2022), s. 68
    Call numberC 3069
    MeSH Subject sarkóm
    kináza anaplastického lymfómu
    skúšanie klinické, fáza II, ako téma
    výsledok liečby
    Keywords nádory inflamatórne myofibroblastické * krizotinib
    Form, Genre abstrakt v angličtine
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.